CNSP News and Press, CNS Pharmaceuticals Inc.

2024-07-03 11:45:35 ET More on CNS Pharmaceuticals CNS Pharmaceuticals drops 6%, prices $1.37M offering Financial information for CNS Pharmaceuticals Read the full article on Seeking Alpha For further details see: CNS Pharmaceuticals announces pricing of ...

A look at the top 10 most actives in the United States Zoomcar Holdings Inc. (ZCAR) rose 58.3% to $0.2162 on volume of 130,087,791 shares Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.1863 on volume of 71,767,970 shares SMX (Security Matters) Public Limited Company (SMX) rose 17.1...

A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 73.0% to $0.4585 on volume of 640,087,036 shares Ocean Power Technologies Inc. (OPTT) rose 34.9% to $0.1812 on volume of 396,326,565 shares NVIDIA Corporation (NVDA) rose 0.2% to $1...

A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 56.4% to $0.21 on volume of 112,154,340 shares Rivian Automotive Inc. (RIVN) rose 31.8% to $15.76 on volume of 70,797,368 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 48.3% to $...

2024-06-26 08:14:52 ET More on CNS Pharmaceuticals CNS Pharmaceuticals drops 6%, prices $1.37M offering Financial information for CNS Pharmaceuticals Read the full article on Seeking Alpha For further details see: CNS Pharmaceuticals stock falls on pricin...

New research carried out by scientists at the University of Birmingham and Newcastle University has determined that a new brain scan could decrease waiting times for diagnosis for children living with brain cancer. The most common form of brain cancer is medulloblastoma, which is further div...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused institutional investors. The ag...

2024-06-17 05:30:19 ET More on CNS Pharmaceuticals Financial information for CNS Pharmaceuticals Read the full article on Seeking Alpha For further details see: CNS Pharmaceuticals drops 6%, prices $1.37M offering

HOUSTON, TX / ACCESSWIRE / June 14, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has entered ...

A look at the top 10 most actives in the United States KWESST Micro Systems Inc. (KWE) rose 117.2% to $0.8686 on volume of 324,599,275 shares NVIDIA Corporation (NVDA) rose 0.7% to $121.79 on volume of 306,257,100 shares Nauticus Robotics Inc. (KITT) rose 49.0% to $0.2309 on volume of 208...